アクセプト論文2022年

• Refractory adult-onset Still's disease complicated with monoclonal gammopathy of undetermined significance: A case report.
  

  筆者	：	Saito K, Asano T, Matsumoto H, Fujita Y, Matsuoka N, Ohkawara H, Sumichika Y, Yoshida S, Temmoku J, Yashiro-Furuya M, Sato S, Watanabe H, Migita K.
  掲載誌	：	Medicine (Baltimore). 2022 Dec 9;101(49)

• Increased CEACAM1 expression on peripheral blood neutrophils in patients with rheumatoid arthritis.
  

  筆者	：	Matsumoto H, Fujita Y, Onizawa M, Saito K, Sumichika Y, Yoshida S, Temmoku J, Matsuoka N, Yashiro-Furuya M, Asano T, Sato S, Suzuki E, Machida T, Watanabe H, Migita K.
  掲載誌	：	Front Immunol. 2022 Dec 14;13:978435.

• Correction: Autoinflammatory disease: clinical perspectives and therapeutic strategies.
  

  筆者	：	Kawakami A, Endo Y, Koga T, Yoshiura KI, Migita K.
  掲載誌	：	Inflamm Regen. 2022 Dec 29;42(1):64.

• The expression of Ets-1 and Fli-1 is associated with interferon-inducible genes in peripheral blood mononuclear cells from Japanese patients with systemic lupus erythematosus.
  

  筆者	：	Suzuki E, Zhang XK, Yashiro-Furuya M, Asano T, Kanno T, Kobayashi H, Migita K, Ohira H.
  掲載誌	：	Medicine (Baltimore). 2022 Nov 11;101(45):e31522.

• New-onset dermatomyositis following COVID-19: A case report.
  

  筆者	：	Shimizu H, Matsumoto H, Sasajima T, Suzuki T, Okubo Y, Fujita Y, Temmoku J, Yoshida S, Asano T, Ohira H, Ejiri Y, Migita K.
  掲載誌	：	Front Immunol. 2022 Oct 24;13:1002329.

• Real-world comparative effectiveness of bDMARDs and JAK inhibitors in elderly patients with rheumatoid arthritis.
  

  筆者	：	Temmoku J, Migita K, Yoshida S, Matsumoto H, Fujita Y, Matsuoka N, Yashiro-Furuya M, Asano T, Sato S, Suzuki E, Watanabe H, Miyata M.
  掲載誌	：	Medicine (Baltimore). 2022 Oct 21;101(42):e31161.

• Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis.
  

  筆者	：	Temmoku J, Miyata M, Suzuki E, Sumichika Y, Saito K, Yoshida S, Matsumoto H, Fujita Y, Matsuoka N, Asano T, Sato S, Watanabe H, Migita K.
  掲載誌	：	PLoS One. 2022 Sep 19;17(9):e0274775.

• Severe Enteritis after Cyclophosphamide Administration in a Patient with Microscopic Polyangiitis: A Case Report and Literature Review.
  

  筆者	：	Yoshida S, Temmoku J, Asano T, Iwasaki T, Matsumoto H, Fujita Y, Yashiro-Furuya M, Matsuoka N, Gunji N, Sato S, Watanabe H, Ohira H, Migita K.
  掲載誌	：	Intern Med. 2022 Sep 13.

• Case Report: Coexistence of Multiple Myeloma and Auricular Chondritis in VEXAS Syndrome.
  

  筆者	：	Matsumoto H, Fujita Y, Fukatsu M, Ikezoe T, Yokose K, Asano T, Tsuchida N, Maeda A, Yoshida S, Hashimoto H, Temmoku J, Matsuoka N, Yashiro-Furuya M, Sato S, Murakami M, Sato H, Sakuma C, Kawashima K, Shakespear N, Uchiyama Y, Watanabe H, Kirino Y, Matsumoto N, Migita K.
  掲載誌	：	Front Immunol. 2022 Jun 9;13:897722.

• Behçet's disease with a somatic UBA1 variant:Expanding spectrum of autoinflammatory phenotypes of VEXAS syndrome.
  

  筆者	：	Matsumoto H, Asano T, Tsuchida N, Maeda A, Yoshida S, Yokose K, Fujita Y, Temmoku J, Matsuoka N, Yashiro-Furuya M, Sato S, Irie K, Norikawa N, Yamamoto T, Endo M, Fukuchi K, Ohkawara H, Ikezoe T, Uchiyama Y, Kirino Y, Matsumoto N, Watanabe H, Migita K.
  掲載誌	：	Clin Immunol. 2022 Apr 7;238:108996.

• Effectiveness of Combination Tocilizumab and Glucocorticoids as an Induction Therapy in Patients with Takayasu Arteritis: An Observational Study.
  

  筆者	：	Yoshida S, Suzuki E, Matsumoto H, Yokose K, Fujita Y, Jumpei T, Matsuoka N, Furuya M, Temmoku J, Asano T, Sato S, Watanabe H, Migita K.
  掲載誌	：	Mod Rheumatol. 2022 Apr 19:roac033.

• Anti-Mi-2 and Anti-TIF1-γ Double-Positive Juvenile Dermatomyositis Treated under Diagnosis of Chronic Eczema: A Case Report.
  

  筆者	：	Yoshida S, Matsumoto H, Fujita Y, Yokose K, Temmoku J, Matsuoka N, Yashiro-Furuya M, Asano T, Sato S, Suzuki E, Yago T, Yaguchi T, Aita T, Kusano M, Yamamoto T, Watanabe H, Migita K.
  掲載誌	：	Tohoku J Exp Med. 2022 Apr 20;256(4):303-308.

• The Expanding Spectrum of Autoinflammatory Diseases.
  

  筆者	：	Migita K, Fujita Y, Asano T, Sato S.
  掲載誌	：	Intern Med. 2022 Mar 19.

• Outcome of Rituximab Treatment in Japanese Patients with ANCA-Associated Vasculitis in Daily Clinical Practice: A Two-Center Study in Fukushima, Japan.
  

  筆者	：	Yashiro-Furuya M, Sato S, Akanuma M, Sato K, Suzuki E, Kanno T, Matsumoto H, Temmoku J, Fujita Y, Matsuoka N, Asano T, Kobayashi H, Watanabe H, Migita K.
  掲載誌	：	Mod Rheumatol. 2022 Mar 26:roac027.

• Clinical Characteristics of Patients With IgG4-Related Disease Complicated by Hypocomplementemia.
  

  筆者	：	Fujita Y, Fukui S, Umeda M, Tsuji S, Iwamoto N, Nakashima Y, Horai Y, Suzuki T, Okada A, Aramaki T, Ueki Y, Mizokami A, Origuchi T, Watanabe H, Migita K, Kawakami A.
  掲載誌	：	Front Immunol. 2022 Feb 24;13:828122.

• Total Hip Joint Replacement in a Patient with Colchicine-Resistant Familial Mediterranean Fever under Canakinumab Treatment.
  

  筆者	：	Matsumoto H, Ohashi H, Fujita Y, Yoshida S, Yokose K, Temmoku J, Matsuoka N, Shinden Y, Kusano K, Sonobe T, Nakamoto Y, Yashiro-Furuya M, Asano T, Sato S, Suzuki E, Yago T, Watanabe H, Migita K.
  掲載誌	：	Tohoku J Exp Med. 2022 Feb;256(2):169-174.

• Effect of a multitarget therapy with prednisolone, mycophenolate mofetil, and tacrolimus in a patient with type B insulin resistance syndrome complicated by lupus nephritis.
  

  筆者	：	Temmoku J, Asano T, Saito K, Matsumoto H, Fujita Y, Furuya-Yashiro M, Matsuoka N, Oda A, Tanabe H, Sato S, Shio-Yano K, Sasajima T, Kiko Y, Kobayashi H, Watanabe H, Shimabukuro M, Migita K.
  掲載誌	：	Mod Rheumatol Case Rep. 2022 Jan 7;6(1):41-46.

• Genetic risk factors for autoimmune hepatitis: implications for phenotypic heterogeneity and biomarkers for drug response.
  

  筆者	：	Higuchi T, Oka S, Furukawa H, Tohma S, Yatsuhashi H, Migita K.
  掲載誌	：	Hum Genomics. 2021 Jan 28;15(1):6.